Drug Profile
Research programme: anti-tumour necrosis factor inhibitor - Peptinov
Alternative Names: Anti-TNF inhibitor - Peptinov; Anti-TNF small molecule inhibitor - Peptinov; Anti-tumour necrosis factor inhibitor - PeptinovLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Peptinov
- Class Small molecules
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Septic shock
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Septic-shock in France (Intraperitoneal, Injection)
- 28 Aug 2020 No recent reports of development identified for research development in Septic-shock in France (PO)
- 25 Jul 2016 Early research in Septic shock in France (Intraperitoneal)